Kira

Seiger

MD

MBA

APPOINTMENTS

UW Medical Center – Roosevelt Dermatology Center 

206.598.4067
Schedule Online

4225 Roosevelt Way NE, Floor 4
Seattle, WA 98105

Harborview Medical Center

206.520.5000
Schedule Online

325 9th Ave
West Clinic, Floor 3
Box 359763
Seattle, WA 98104

BIOGRAPHY

Kira Seiger, MD, MBA, (she/her/hers) is an Acting Professor in the UW Department of Dermatology and a board-certified dermatologist at the UW Medical Center–Roosevelt Dermatology Center and the Harborview Medical Center. She oversees process and quality improvement activities as the Director of Quality Improvement (QI)—with the goal of improving patient outcomes, achieving efficiency, and reducing costs.

Dr. Seiger earned her BA in Human Biology with a Concentration in Health Management and Policy at Stanford University in 2014. She earned her MD and MBA simultaneously at Harvard Medical School and Harvard Business School, completing both in 2020. Dr. Seiger completed her Internal Medicine Internship in 2021 at Kaiser Permanente Oakland Medical Center. She then went on to complete her Dermatology Residency at the University of California, San Francisco, and recently graduated from the program in 2024.   

Dr. Seiger specializes in quality improvement initiatives, health systems advocacy, and cost analysis.

EDUCATION & TRAINING

Resident Physician of Dermatology, University of California, San Francisco (2021-2024)

Internal Medicine Preliminary Resident Physician, Kaiser Permanente Oakland Medical Center (2020-2021) 

MBA, Harvard Business School (2018-2020)

MD, Harvard Medical School (2015-2020)

BA,  Human Biology with Honors and Distinction with a Concentration in Health Management and Policy, Stanford University (2010-2014)

HONORS

Excellence in Patient Care Award: Resident Quality Improvement Award, American Academy of Dermatology (2024)

2nd Place (Honorable Mention), Leon Eisenberg Prize for Medicine in Society Research, Harvard Medical School (2019)

Value Based Health Care Intensive Seminar, (1 of 2 students selected for the international cohort of 85 healthcare professionals from 16 countries), Professor Michael E. Porter, Harvard Business School (2019)

Student Leadership Program, Stanford Medicine X Conference, Stanford University (2016) 

Judge on the National Review Board, US Department of Education’s Career and Technical Education (CTE) Makeover Challenge (2016)

RESEARCH & CLINICAL INTERESTS

• Quality Improvement (QI)
• Health Systems Advocacy
• Cost Analysis

SELECTED PUBLICATIONS

Guo, L., Jacobson, R., Vaughan, H., Connolly, K.M., Seiger, K., Haemel, A.K., North, J. C3d Immunohistochemistry in the Diagnosis of Bullous Pemphigoid: A Comparative Diagnostic Test Accuracy and Cost Analysis Study. J Am Acad Dermatol. 2023, Apr; S0190-9622(23)00713-2. Cited in PubMed; PMID: 37080338. 

Wu, D., Lee, E.Y., Lifton, J., Zullo, S.W., Seiger, K., Nadadur, R., Fox, L.P., Escobar, D.J., Dobry, A.S., Yung, M., Kangelaris, K.N., Arakaki, R. Severe Recurrence of Reactive Infectious Mucocutaneous Eruption with Extensive Ocular Involvement in an Adult due to SARS-CoV-2. JAAD Case Rep. 2023, Feb; 36:1–3. Cited in PubMed; PMID: 36819988. 

Mendoza, M.G., Azoulay, M., Chang, S.D., Gibbs, I.C., Hancock, S.L., Pollom, E.L., Adler, J.R., Harraher, C., Li, G., Gephart, M.H., Nagpal, S., Thomas, R.P., Recht, L.D., Jacobs, L.R., Modlin, L.A., Wynne, J., Seiger, K., Fujimoto, D., Usoz, M., von Eyben, R., Choi, C.Y.H., Soltys, S.G. Patterns of Progression in Patients With Newly Diagnosed Glioblastoma Treated With 5-mm Margins in a Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With Concurrent and Adjuvant Temozolomide. Pract Radiat Oncol. 2023, May-Jun; 13(3):e239-e245. Cited in PubMed; PMID: 36736621.

Rahimy, E., Dudley, S.A., von Eyben, R., Pollom, E., Seiger, K., Modlin, L,. Wynne, J., Fujimoto, D., Jacobs, L.R., Chang, S., Gibbs, I., Hancock, S., Adler, J.R., Li, G., Choi, C.Y.H., Soltys, S. Phase I/II Dose-Escalation Trial of 3-Fraction Stereotactic Radiosurgery for Resection Cavities from Large Brain Metastases: Health-Related Quality of Life Outcomes. Am J Clin Oncol. 2021, Nov; 44(11): 588-595. Cited in PubMed; PMID: 34670228. 

Seiger, K., Tkachenko, E., Mostaghimi, A. Growth of Private Equity in Dermatology Through Acquisitions and New Clinic Formation, 2018-2019. J Am Acad Dermatol. 2021, Jul;85(1):263-264. Cited in PubMed; PMID: 32950552.